Bridgefront Capital’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,028
Closed -$149K 593
2025
Q3
$149K Buy
+15,028
New +$156K 0.04% 540
2025
Q2
Sell
-35,006
Closed -$454K 664
2025
Q1
$454K Buy
+35,006
New +$463K 0.13% 282
2024
Q3
Sell
-36,211
Closed -$407K 580
2024
Q2
$407K Buy
36,211
+24,247
+203% +$282K 0.17% 214
2024
Q1
$148K Buy
+11,964
New +$156K 0.11% 336

Other funds holding DVAX

Bridgefront Capital's DVAX Position: Q4 2025 in Review

Bridgefront Capital sold out of Dynavax Technologies (DVAX) in Q4 2025, closing a stake of 15,028 shares — an estimated $149K sold.

Bridgefront Capital first reported a position in DVAX in Q1 2024 and held it in 4 quarters. The position peaked at $454K in Q1 2025. 266 funds tracked by Wall St. Rank hold DVAX as of Q4 2025.

  • Bridgefront Capital reported no remaining Dynavax Technologies position as of Q4 2025 after selling out during the quarter.
  • Bridgefront Capital sold 15,028 Dynavax Technologies shares in Q4 2025, an estimated $149K.
  • Bridgefront Capital first reported a position in Dynavax Technologies in Q1 2024 and held it in 4 quarters.
  • Bridgefront Capital's Dynavax Technologies position peaked at $454K in Q1 2025.
  • 266 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2025.

Based on Bridgefront Capital's 13F filing for Q4 2025, filed 13 Feb 2026.